- Home
- HNNA vs RGC Comparison
HNNA vs RGC Comparison
Compare HNNA & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- RGC
- Stock Information
- Founded
- HNNA 1989
- RGC 2014
- Country
- HNNA United States
- RGC Hong Kong
- Employees
- HNNA N/A
- RGC N/A
- Industry
- HNNA Investment Managers
- RGC Medicinal Chemicals and Botanical Products
- Sector
- HNNA Finance
- RGC Health Care
- Exchange
- HNNA Nasdaq
- RGC Nasdaq
- Market Cap
- HNNA 94.3M
- RGC 105.3M
- IPO Year
- HNNA N/A
- RGC 2021
- Fundamental
- Price
- HNNA $12.44
- RGC $4.82
- Analyst Decision
- HNNA
- RGC
- Analyst Count
- HNNA 0
- RGC 0
- Target Price
- HNNA N/A
- RGC N/A
- AVG Volume (30 Days)
- HNNA 15.2K
- RGC 6.7K
- Earning Date
- HNNA 02-06-2025
- RGC 10-25-2024
- Dividend Yield
- HNNA 4.44%
- RGC N/A
- EPS Growth
- HNNA 46.17
- RGC N/A
- EPS
- HNNA 0.92
- RGC N/A
- Revenue
- HNNA $29,646,000.00
- RGC N/A
- Revenue This Year
- HNNA N/A
- RGC N/A
- Revenue Next Year
- HNNA N/A
- RGC N/A
- P/E Ratio
- HNNA $13.52
- RGC N/A
- Revenue Growth
- HNNA 23.42
- RGC N/A
- 52 Week Low
- HNNA $6.38
- RGC $3.03
- 52 Week High
- HNNA $13.88
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- HNNA 55.31
- RGC 44.37
- Support Level
- HNNA $11.64
- RGC $4.81
- Resistance Level
- HNNA $13.54
- RGC $4.95
- Average True Range (ATR)
- HNNA 0.65
- RGC 0.24
- MACD
- HNNA -0.06
- RGC 0.03
- Stochastic Oscillator
- HNNA 44.16
- RGC 19.92
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.